"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
Methylene Blue Injection, USP 1%
(FOR INTRAVENOUS INJECTION)
- Patient Information:
Details with Side Effects
Methylene Blue (methylene blue injection) Injection, USP is a sterile solution of methylene blue (methylene blue injection) in water for injection suitable for parenteral administration.
C16H18ClN3S MW = 319.86
Each mL of solution contains 10 mg of methylene blue (methylene blue injection) .
Last reviewed on RxList: 7/22/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Methylene Blue Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.